A Surprisingly Consistent Relationship for JETS and Traveler Throughput

The Relationship At its height last March, the U.S. Global Jets ETF (JETS) still could not close all its pandemic-driven losses. JETS was a 5.9% gain from finally returning to where it last traded at its 200-day moving average (DMA) (the blue line in the stock chart below). Similarly, the number of travelers at U.S. … Read more

A Fresh Crack in the Stock Market’s Complacency

A Fresh Crack from the Currency Market At the time of writing, the Australian dollar versus the Japanese yen (AUD/JPY) is falling below its 50-day moving average (DMA) (the red line in the chart below) for the first time since last September. This move is the latest yellow, perhaps red, flag on the stock market … Read more

ReneSola Finally Broke the Bank

ReneSola (SOL) is down 64.9% from its near 10-year high set in January. The company celebrated that high by announcing a secondary stock offering…its fifth in 4 months. SOL came back stronger and better from the first four secondaries of the series. The fifth secondary stock offering finally broke the bank (meaning ReneSola overwhelmed the … Read more

Why Soliton Sold Off on Good News from the FDA

As highly anticipated, medical device maker Soliton (SOLY) announced the company received approval from the FDA for the cellulite indication of its Rapid Acoustic Pulse (“RAP”) technology. SOLY initially opened on February 1st with a 17.3% gain, but the stock ended the day with a 3.6% gain. Why did Soliton sell off after this good … Read more